Skip to main content
Premium Trial:

Request an Annual Quote

SpeeDx, UgenTec Collaborate on Interpretation for Infectious Disease Dx Results

NEW YORK (GenomeWeb) – Australian diagnostics firm SpeeDx has announced that Belgian software maker UgenTec will provide interpretation for results generated by the firm's infectious disease diagnostics.

UgenTec's FastFinder software offers automated data analysis for PCR applications and has already been incorporated as an interpretation module for SpeeDx's ResistancePlus MG, which detects the sexually-transmitted infectious bacterium Mycoplasma genitalium as well as a gene that confers resistance to the antibiotic azithromycin.

SpeeDx said in a statement that it plans to add FastFinder to its PlexPCR HSV-1&2, VZV, Syphilis and PlexPCR RespiVirus products as well.

"We can now provide a validated solution for multiple qPCR instruments to help speed the delivery of results during routine diagnostic use," SpeeDx CEO Colin Denver said in a statement.

Financial and other terms of the arrangement were not disclosed.

SpeeDx recently opened offices in Europe to help launch its CE-marked tests.